Physician

David Paul Boysen, M.D.

According to 2025 Medicare claims, David Boysen, M.D. (NPI: 1972687911) practices dermatology in the Iowa City, IA market, with the plurality of this provider's patient population coming from Johnson, IA. This provider's primary affiliated billing organization is EPIPHANY DERMATOLOGY OF IOWA, PLC (NPI: 1104451749; TIN: 844900614) and primary practice location at 52241-1774.

Boysen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 978 traditional Medicare patients, billed 4,919 HCPCS/CPT codes, and received $194,262 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 513 prescription claims across 237 beneficiaries totaling $12,374 in drug costs, led by Metronidazole (Metronidazole). Open Payments data shows 6 records totaling $100. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $31,537 to $12,374. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$125K$250K2015 Medicare payment: $230,631 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $234,289 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $240,803 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $215,427 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $193,587 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $170,637 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $250,269 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $225,328 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $202,557 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $194,262 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,3086,187$230,631
20161,3535,942$234,289
20171,3565,936$240,803
20181,2795,749$215,427
20191,1835,425$193,587
20201,0114,378$170,637
20211,1655,046$250,269
20221,0814,888$225,328
20231,0504,585$202,557
20249784,919$194,262

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$32K2015 Drug cost: $31,537 (USD; Tot_Drug_Cst)2016 Drug cost: $28,082 (USD; Tot_Drug_Cst)2017 Drug cost: $22,512 (USD; Tot_Drug_Cst)2018 Drug cost: $24,738 (USD; Tot_Drug_Cst)2019 Drug cost: $26,106 (USD; Tot_Drug_Cst)2020 Drug cost: $18,443 (USD; Tot_Drug_Cst)2021 Drug cost: $15,943 (USD; Tot_Drug_Cst)2022 Drug cost: $15,006 (USD; Tot_Drug_Cst)2023 Drug cost: $12,338 (USD; Tot_Drug_Cst)2024 Drug cost: $12,374 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015248457$31,537
2016294573$28,082
2017262507$22,512
2018276566$24,738
2019262540$26,106
2020204432$18,443
2021229438$15,943
2022218459$15,006
2023191413$12,338
2024237513$12,374

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth97103$61
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8581,126$53
17000Destruction of precancer skin growth, 1 growth580784$38
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more157176$36
17003Destruction of precancer skin growth, 2-14 growths4162,194$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MetronidazoleMetronidazole34929$2,078
Doxycycline MonohydrateDoxycycline Monohydrate601,717$1,728
FluorouracilFluorouracil12271$956
ValacyclovirValacyclovir Hcl28940$878
FluocinonideFluocinonide20584$690

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$100ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Paul Boysen, M.D.?

Tedicare shows public-source Medicare data for David Paul Boysen, M.D. (NPI 1972687911), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Paul Boysen, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Paul Boysen, M.D.?

David Paul Boysen, M.D. is linked to EPIPHANY DERMATOLOGY OF IOWA, PLC (billing NPI 1104451749) in the available physician profile data.

Does David Paul Boysen, M.D. have Open Payments data?

David Paul Boysen, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.